Last updated: December 13, 2022
Sponsor: University Hospital, Lille
Overall Status: Active - Recruiting
Phase
N/A
Condition
Endometriosis
Ovarian Cysts
Treatment
N/AClinical Study ID
NCT03823833
2018_48
Ages 18-35 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- women with benign ovarian tumor with high risk of recurrence, i-e, endometrioma,dermoid cysts or mucinous cysts.
- women with previous surgery and/or high risk of ovarian damage: bilateral cysts, cystdiameter higher than 5 cms
- Having a social insurance
- Able to give an informed consent
Exclusion
Exclusion Criteria:
- Borderline tumors
- Undetectable AMH levels
- Personal history of thrombo-embolic events
- pregnancy
Study Design
Total Participants: 100
Study Start date:
July 28, 2021
Estimated Completion Date:
December 31, 2022
Connect with a study center
Hop Jeanne de Flandre Chu Lille
Lille, 59037
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.